116 related articles for article (PubMed ID: 28686109)
1. α-Adducin gene promoter DNA methylation and the risk of essential hypertension.
Bayoumy NMK; El-Shabrawi MM; Leheta OF; Omar HH
Clin Exp Hypertens; 2017; 39(8):764-768. PubMed ID: 28686109
[TBL] [Abstract][Full Text] [Related]
2. Lower ADD1 gene promoter DNA methylation increases the risk of essential hypertension.
Zhang LN; Liu PP; Wang L; Yuan F; Xu L; Xin Y; Fei LJ; Zhong QL; Huang Y; Xu L; Hao LM; Qiu XJ; Le Y; Ye M; Duan S
PLoS One; 2013; 8(5):e63455. PubMed ID: 23691048
[TBL] [Abstract][Full Text] [Related]
3. The interactions between alcohol consumption and DNA methylation of the ADD1 gene promoter modulate essential hypertension susceptibility in a population-based, case-control study.
Han L; Liu P; Wang C; Zhong Q; Fan R; Wang L; Duan S; Zhang L
Hypertens Res; 2015 Apr; 38(4):284-90. PubMed ID: 25567773
[TBL] [Abstract][Full Text] [Related]
4. Association of AGTR1 Promoter Methylation Levels with Essential Hypertension Risk: A Matched Case-Control Study.
Fan R; Mao S; Zhong F; Gong M; Yin F; Hao L; Zhang L
Cytogenet Genome Res; 2015; 147(2-3):95-102. PubMed ID: 26658476
[TBL] [Abstract][Full Text] [Related]
5. Hypomethylation of interleukin-6 (IL-6) gene increases the risk of essential hypertension: a matched case-control study.
Mao SQ; Sun JH; Gu TL; Zhu FB; Yin FY; Zhang LN
J Hum Hypertens; 2017 Aug; 31(8):530-536. PubMed ID: 28300071
[TBL] [Abstract][Full Text] [Related]
6. Hypomethylation of the Interferon γ Gene as a Potential Risk Factor for Essential Hypertension: A Case-Control Study.
Bao XJ; Mao SQ; Gu TL; Zheng SY; Zhao JS; Zhang LN
Tohoku J Exp Med; 2018 Apr; 244(4):283-290. PubMed ID: 29643275
[TBL] [Abstract][Full Text] [Related]
7. Preliminary analysis of the association between methylation of the ACE2 promoter and essential hypertension.
Fan R; Mao SQ; Gu TL; Zhong FD; Gong ML; Hao LM; Yin FY; Dong CZ; Zhang LN
Mol Med Rep; 2017 Jun; 15(6):3905-3911. PubMed ID: 28440441
[TBL] [Abstract][Full Text] [Related]
8. Association of SCNN1B promoter methylation with essential hypertension.
Zhong Q; Liu C; Fan R; Duan S; Xu X; Zhao J; Mao S; Zhu W; Hao L; Yin F; Zhang L
Mol Med Rep; 2016 Dec; 14(6):5422-5428. PubMed ID: 27840946
[TBL] [Abstract][Full Text] [Related]
9. Interactions between
Gu T; Mao S; Fan R; Zhong F; Zhu F; Hao L; Zhang L; Yin F
Biomed Res Int; 2016; 2016():1454186. PubMed ID: 28078278
[TBL] [Abstract][Full Text] [Related]
10. Hypomethylation of the Toll-like receptor-2 gene increases the risk of essential hypertension.
Mao S; Gu T; Zhong F; Fan R; Zhu F; Ren P; Yin F; Zhang L
Mol Med Rep; 2017 Jul; 16(1):964-970. PubMed ID: 28560381
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation of the GCK gene body is associated with the risk of essential hypertension.
Fan R; Wang WJ; Zhong QL; Duan SW; Xu XT; Hao LM; Zhao J; Zhang LN
Mol Med Rep; 2015 Aug; 12(2):2390-4. PubMed ID: 25892191
[TBL] [Abstract][Full Text] [Related]
12. Alpha Adducin (ADD1) Gene Polymorphism and New Onset of Diabetes Under the Influence of Selective Antihypertensive Therapy in Essential Hypertension.
Gupta S; Jhawat V; Agarwal BK; Roy P; Saini V
Curr Hypertens Rev; 2019; 15(2):123-134. PubMed ID: 30062972
[TBL] [Abstract][Full Text] [Related]
13. Association of mitofusin 2 methylation and essential hypertension: a case-control study in a Chinese population.
Jin F; Li X; Wang Z; Liu Y; Liu J; Sun D; Jin Y; Wang S; Wen S; Wei Y
Hypertens Res; 2018 Aug; 41(8):605-613. PubMed ID: 29880838
[TBL] [Abstract][Full Text] [Related]
14. Relationship between ADD1 Gly460Trp gene polymorphism and essential hypertension in Madeira Island.
Sousa AC; Palma Dos Reis R; Pereira A; Borges S; Freitas AI; Guerra G; Góis T; Rodrigues M; Henriques E; Freitas S; Ornelas I; Pereira D; Brehm A; Mendonça MI
Medicine (Baltimore); 2017 Oct; 96(42):e7861. PubMed ID: 29049185
[TBL] [Abstract][Full Text] [Related]
15. Methylation level of CpG islands in GGH gene promoter in pediatric acute leukemia.
Li Y; Liu S; Wang H; Mai H; Yuan X; Li C; Chen X; Wen F
PLoS One; 2017; 12(3):e0173472. PubMed ID: 28278270
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation in the norepinephrine transporter gene promoter region is not associated with depression and hypertension.
Meng L; Chen D; Pei F; Hui R; Zheng Y; Chen J
Clin Exp Hypertens; 2017; 39(6):539-545. PubMed ID: 28737436
[TBL] [Abstract][Full Text] [Related]
17. Association of APP gene polymorphisms and promoter methylation with essential hypertension in Guizhou: a case-control study.
Li R; Song J; Zhao A; Diao X; Zhang T; Qi X; Guan Z; An Y; Ren L; Wang C; He Y
Hum Genomics; 2023 Mar; 17(1):25. PubMed ID: 36941702
[TBL] [Abstract][Full Text] [Related]
18. No association between IRS‑1 promoter methylation and type 2 diabetes.
Ma J; Cheng J; Wang L; Wang H; Xu L; Liu P; Bu S; Zhang L; Le Y; Ye M; Wang Q; Shi Y; Duan S
Mol Med Rep; 2013 Sep; 8(3):949-53. PubMed ID: 23828647
[TBL] [Abstract][Full Text] [Related]
19. α-Adducin gene G614T polymorphisms in essential hypertension patients with high low density lipoprotein (LDL) levels.
Wang L; Zheng B; Zhao H; Du P; Sun A; Hua K; Gao Y
Indian J Med Res; 2014 Feb; 139(2):273-8. PubMed ID: 24718403
[TBL] [Abstract][Full Text] [Related]
20. Alpha Adducin G460T Variant is a Risk Factor for Hypertension in Tunisian Population.
Soualmia H; Ben Romdhane A; Midani F; Kallel A; Jemaa R; Feki M; Kaabachi N
Clin Lab; 2016; 62(5):765-70. PubMed ID: 27349000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]